ğŸ§¬ IVF Coverage & Cost Impact Analysis â€” CA SB 729 (2024)
This project was conducted in response to California Senate Bill 729 (SB 729), which mandates that self-funded employers in California must provide IVF (in vitro fertilization) benefits beginning in 2024.

The objective was to analyze the financial impact of IVF coverage using medical claims data and to estimate both the current cost of IVF treatment and the rate of utilization among eligible members.

ğŸ”’ Note: All company-specific data has been replaced with mock data to preserve confidentiality. Logic, structure, and methodology remain reflective of the original study.

ğŸ’¼ Project Overview
Policy Context: CA SB 729 requires IVF coverage for self-funded employer health plans.

Collaboration: Partnered with the Actuarial Team to:

Identify IVF-related claims in the 2024 dataset

Quantify average IVF treatment costs

Estimate prevalence of IVF treatment in the employer population

Tools Used: SQL, Python (Pandas, Matplotlib), Excel, Actuarial models

ğŸ’¸ Cost & Financial Impact Summary
ğŸ“Š National IVF Cost (Actuarial Benchmarks)
Estimated average IVF cost per treatment cycle in 2024:
$15,000 to $25,000, depending on geography, provider, and treatment plan

Geographic variation and member demographics affect pricing significantly

ğŸ§¾ Health Plan Impact
Expected financial impact to employer medical plans:

1% to 2% of total medical spend

May vary based on region, plan design, and member utilization patterns

âš–ï¸ Plan Design Considerations
IVF coverage must align with other core plan features per SB 729 (e.g., cost-sharing parity)

Employers should consult legal counsel to ensure benefit compliance with SB 729

ğŸ“š Source: Marsh McLennan Agency â€” SB 729 Overview

ğŸ“ Repository Contents
data/: Mock claims data including IVF-related procedure and diagnosis codes

notebooks/: Jupyter notebook with data cleaning, cost analysis, and visualization

ivf_analysis.py: Core logic for cost aggregation and member-level analysis

README.md: Project summary and background (this file)

ğŸ“Œ Key Takeaways
IVF treatment remains a high-cost, low-prevalence benefit, but critical for equity and parity

Legislative compliance (SB 729) requires thoughtful plan design and cost forecasting

This analysis supports financial modeling, compliance planning, and employer decision-making
